Join MBX Biosciences for an in-person and virtual Obesity Day featuring Richard DiMarchi, PhD (Distinguished Professor of Chemistry, Indiana University; Scientific Co-Founder, MBX Biosciences, Inc.) and Katherine H. Saunders, MD (Co-Founder, FlyteHealth; Clinical Assistant Professor of Medicine, Weill Cornell Medicine), who will join company management to discuss the evolving treatment landscape and remaining treatment gaps in obesity.

The event will include an overview of MBX’s Precision Endocrine Peptide^TM(PEP^TM) platform and its application to the development of long-acting peptide therapies for obesity, as well as an update on the Company’s obesity product candidates.

A live Q&A session will follow the formal presentations.

The live webcast can be accessed in the Events section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events.